The linkage between hemoglobin-to-red blood cell distribution width ratio and osteoarthritis: a study based on the national health and nutrition examination survey.
Wuyang Zhou, Guanfeng Lu, Jing Wang, Shujuan Fan, Gang Fang
{"title":"The linkage between hemoglobin-to-red blood cell distribution width ratio and osteoarthritis: a study based on the national health and nutrition examination survey.","authors":"Wuyang Zhou, Guanfeng Lu, Jing Wang, Shujuan Fan, Gang Fang","doi":"10.1080/17474086.2026.2634991","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Inflammation is crucial in osteoarthritis (OA) pathogenesis. The hemoglobin-to-red cell distribution width ratio (HRR), an emerging inflammatory marker, remains unclear regarding its connection with OA.</p><p><strong>Research design and methods: </strong>This study was based on National Health and Nutrition Examination Survey (NHANES) data spanning 2003-2016, covering 13,453 participants. Weighted logistic regression assessed the HRR-OA association. Subgroup and interaction analyses evaluated differences across populations.</p><p><strong>Results: </strong>After adjusting for all confounders in the model, a negative association between HRR and OA (Odds Ratio (OR) = 0.56, 95% Confidence Interval (CI): 0.34-0.93) was detected. Compared to the lowest quartile, the third and highest HRR quartiles were associated with 23% (OR = 0.77) and 34% (OR = 0.66) lower OA odds, respectively. This inverse association was stronger in subgroups including individuals ≥65 years, males, and those widowed/divorced/separated. Marital status showed a significant interaction effect.</p><p><strong>Conclusions: </strong>HRR is negatively correlated with the risk of OA and may serve as a potential relevant biological marker. Future studies could further confirm the linkage between HRR and OA by integrating imaging assessments with clinical evaluations.</p>","PeriodicalId":12325,"journal":{"name":"Expert Review of Hematology","volume":" ","pages":"571-577"},"PeriodicalIF":2.8000,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Review of Hematology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/17474086.2026.2634991","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/2/24 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Inflammation is crucial in osteoarthritis (OA) pathogenesis. The hemoglobin-to-red cell distribution width ratio (HRR), an emerging inflammatory marker, remains unclear regarding its connection with OA.
Research design and methods: This study was based on National Health and Nutrition Examination Survey (NHANES) data spanning 2003-2016, covering 13,453 participants. Weighted logistic regression assessed the HRR-OA association. Subgroup and interaction analyses evaluated differences across populations.
Results: After adjusting for all confounders in the model, a negative association between HRR and OA (Odds Ratio (OR) = 0.56, 95% Confidence Interval (CI): 0.34-0.93) was detected. Compared to the lowest quartile, the third and highest HRR quartiles were associated with 23% (OR = 0.77) and 34% (OR = 0.66) lower OA odds, respectively. This inverse association was stronger in subgroups including individuals ≥65 years, males, and those widowed/divorced/separated. Marital status showed a significant interaction effect.
Conclusions: HRR is negatively correlated with the risk of OA and may serve as a potential relevant biological marker. Future studies could further confirm the linkage between HRR and OA by integrating imaging assessments with clinical evaluations.
期刊介绍:
Advanced molecular research techniques have transformed hematology in recent years. With improved understanding of hematologic diseases, we now have the opportunity to research and evaluate new biological therapies, new drugs and drug combinations, new treatment schedules and novel approaches including stem cell transplantation. We can also expect proteomics, molecular genetics and biomarker research to facilitate new diagnostic approaches and the identification of appropriate therapies. Further advances in our knowledge regarding the formation and function of blood cells and blood-forming tissues should ensue, and it will be a major challenge for hematologists to adopt these new paradigms and develop integrated strategies to define the best possible patient care. Expert Review of Hematology (1747-4086) puts these advances in context and explores how they will translate directly into clinical practice.